Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces
- PMID: 32363512
- DOI: 10.1245/s10434-020-08508-4
Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces
Erratum in
-
Correction to: Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces.Ann Surg Oncol. 2020 Dec;27(Suppl 3):981-982. doi: 10.1245/s10434-020-08840-9. Ann Surg Oncol. 2020. PMID: 32643001
Abstract
Objectives: Subsolid lung adenocarcinoma with cystic airspaces (LACA) is a unique manifestation of lung cancer. This study was conducted to establish a radiologic disease progression model of LACA and to explore its association with the clinical course and clinicopathologic features of LACA.
Materials and methods: Sixty patients with LACA who underwent surgery at our center between 2004 and 2017 were retrospectively reviewed. The morphological changes of LACA over time on 98 serial computed tomography scans from 27 of 60 patients were tracked to establish a radiologic disease progression model. Associations between this model and the clinicopathologic characteristics of LACA were investigated.
Results: The following stepwise progression model of LACA was developed: in phase I, cystic airspaces (CAs) appear in the middle of non-solid nodules; in phase II, the CAs grow; in phase III, a solid component appears on the border of the CAs; and in phase IV, the solid component gradually surrounds the CAs and becomes thicker, and the CAs shrink. In total, 10 (17%), 33 (55%), and 17 (28%) LACA patients were classified as belonging to phases II, III, and IV at the time of surgery, respectively. More advanced phases were associated with higher pathologic T and N staging, lymphovascular invasion, visceral pleural invasion, spread through air spaces, and solid/micropapillary subtype. In the multivariate analysis, our model demonstrated a good discrimination capability for cancer recurrence risk.
Conclusions: The stepwise disease progression model of LACA based on radiologic findings developed in this study represented its natural clinical course and clinicopathologic features well.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J clin. 2016;66(1):7–30.
-
- Ujiie H, Kadota K, Chaft JE, et al. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival. J Clin Oncol. 2015;33(26):2877–84. https://doi.org/10.1200/jco.2015.60.9818 . - DOI - PubMed - PMC
-
- Chen C-Y, Wang J-Y, Chien Y-C, et al. Lung cancer mimicking pulmonary tuberculosis in a TB-endemic country: the role of early invasive diagnostic procedures. Lung Cancer Manag. 2015;4(1):9–16.
-
- Tomimaru Y, Higashiyama M, Okami J, et al. Surgical Results of Lung Cancer with Sarcoid Reaction in Regional Lymph Nodes. Jpn J Clin Oncol. 2007;37(2):90–95. https://doi.org/10.1093/jjco/hyl141 . - DOI - PubMed
-
- Ichikawa T, Hattori A, Suzuki K, et al. Clinicopathological characteristics of lung cancer mimicking organizing pneumonia on computed tomography—a novel radiological entity of pulmonary malignancy. Jpn J Clin Oncol. 2016;46(7):681–86. https://doi.org/10.1093/jjco/hyw053 . - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
